The growth of DFA III-assimilating bacteria in the intestines of rats fed 3% DFA III for 2 weeks was examined. Sixty-four percent of the DFA III intake had been assimilated on day 3 of ingestion, and almost all of the DFA III was assimilated at the end of the experiment. The DFA III-assimilating bacterium, Ruminococcus productus, in DFA III-fed rats was in the stationary state of 10 8 -10 9 cells/g dry feces within a week from 10 6 cells/g dry feces on day 1 of DFA III ingestion. The number of R. productus cells was associated with the amount of DFA III excreted in the feces. The acetic acid produced from DFA III by R. productus lowered the cecal pH to 5.8. In control-fed rats and DFA III-fed rats, 94% of secondary bile acids and 94% of primary bile acids, respectively, were accounted for in the total bile acids analyzed. DFA III ingestion increased the ratio of primary bile acids and changed the composition of fecal bile acids.
INTRODUCTION
Difructose anhydride III (di-D-fructofuranose-1,2': 2,3'-dianhydride, DFA III) is a nondigestible disaccharide and is produced in large quantities from inulin using inulase II from Arthrobacter sp. H65-7 (1, 2) . DFA III has half the sweetness of sucrose, is stable in acid and at high temperature, and absorbs less moisture. DFA III was reported to enhance calcium absorption in vivo (3-5) and in vitro experiments (6-8). It directly affects the epithelial tissue and activates the passage of tight junctions which are located on the luminal side of adjacent epithelial cells (7) .
When rats were fed 3% DFA III for 4 weeks, the effects of DFA III administration AIN-93G formulation (24). All the rats were fed the assigned test diets and tap water for 2 weeks. Body weight and food intake were measured daily. At the end of the experiment, the rats were sacrificed after the application of sodium pentobarbital (70 mg/kg body weight; Nembutal, Abbott Laboratories, North Chicago, IL, USA). The cecum was removed with its contents, and the contents were quickly collected and weighed. A portion of these contents for the isolation of DFA III-assimilating bacteria was quickly placed into test tubes containing the diluted solution for anaerobic bacteria (4.5 g of KH 2 PO 4 , 6.0 g of Na 2 HPO 4 , 0.5 g of Tween 80, 0.5 g of L-cysteine hydrochloride and 1.0 g of agar per liter) (25). The remaining cecal contents were immediately frozen in liquid nitrogen and stored at -40°C for subsequent analyses. Fecal samples were collected on days 1, 2, 3, 4, 7 (days 5-7 were pooled) and 14 (days 11-14 were pooled) from DFA III-fed rats and on day 14 (days 11-14 were pooled) from control-fed rats.
This study design was approved by Hokkaido University Animal Committee, and throughout this study the animals were maintained in accordance with Hokkaido University's guidelines for the care and use of laboratory animals.
Isolation and identification of DFA III-assimilating bacteria DFA III-assimilating bacteria were isolated as described previously (9) . Sugar assimilation tests, 16S rDNA sequencing and cell morphology analysis of isolates were also performed as described previously (9). The biochemical features of the isolates were examined using the API 50 CH and API ZYM (bioMérieux sa, Marcy l'Etoile, France) according to the manufacturer's instructions, except for modification of the medium for API 50 CH and incubation conditions. The medium for API 50 CH contained 26.25 g of GAM without dextrose (Nissui Pharmaceutical, Tokyo), 0.5 g of L-cysteine hydrochloride and 40 ml of 0.2% Bromocresol purple (BCP) solution per liter of deionized water (pH 7.0). API 50 CH and API ZYM were incubated in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI, USA). The biochemical features of R. productus JCM 1471 T were also examined as described and the data were compared with those of the isolates.
DNA extraction
The fecal samples were lyophilized and stored at -20°C until use. Metal corns were added and the samples were disrupted at 2500 rpm for 60 s at 4°C using a Multi-Beads Shocker (Yasui Kikai, Osaka). A homogenized sample (0.02 g (dry weight)) was suspended in UltraClean TM Soil DNA Kit solution (Mo Bio Laboratories, Salana Beach, CA, USA) as described previously (26) with some modifications, such as lysis using lysozyme, labiase and N-acetylmuramidase at 37 o C for 20 min.
Real-time PCR DNA extraction from a 10-fold dilution of the culture broth of isolates was also performed as described above. This DNA solution was used to obtain the standard curve for real-time PCR. To evaluate the efficiency of DNA extraction, the culture broth of isolates was added to homogenized fecal samples. The number of isolated cells stained with crystal violet solution was examined by microscopy using a counting chamber. DNA concentration was measured at 260 nm with a UV-VIS spectrophotometer UV mini 1240 (Shimadzu Seisakusyo, Kyoto).
The primers and TaqMan probes were designed according to the guidelines in the ABI Primer Express software program (Applied Biosystems, Foster City, CA, USA).
Among them, specific primers and a probe for isolates were chosen: the forward primer (Rpro-932F: 5' TCG AAG CAA CGC GAA GAA C 3'), the reverse primer (Rpro-999R: 5' GGG AAG GCC CCG TTA CG 3') and the TaqMan probe (Rpro-956T: 5' FAM-CAA GTC TTG ACA TCC CTC TGA CCG GC-TAMRA 3'). 
DGGE analysis
The DGGE analysis targeting the V3 region of the bacterial 16S rDNA was performed as described in a previous paper (26) with some modifications. The second-round PCR was performed using 1µl of the first-round PCR products as the template and 10% polyacrylamide gels contained a 40% to 55% gradient of urea-formamide. The DGGE fragments (gel pieces) were excised with a razor blade, washed once using autoclaved water, directly subjected to PCR and identified. Homogenized fecal samples (20 mg) were suspended in ethanol (0.5 ml) containing 1 M NaOH and internal standard (NDCA, 50 nmol), and bile acids were extracted twice at 80°C for 1 h. The samples were centrifuged at 15,000 rpm for 5 min, and then the supernatant was removed. Neutral sterol was removed by hexane, and then the samples were subjected to a solid-phase extraction using a Bond Elut ® C 18 cartridge (Varian, Harbor City, CA, USA). Bile acids were eluted from the cartridge with ethanol, and the organic solution was evaporated to dryness. The acids were redissolved in methanol, and divided into two portions. One portion was used to examine the concentration of total bile acids (kit # 431-15001; Wako Pure Chemical Industries Tomy Seiko, Tokyo) and centrifuged at 13,000 rpm for 10 min. The supernatant was removed and degreased with chloroform. The amount of DFA III was measured by HPLC (Jasco, Tokyo) using a high-performance carbohydrate column (4.6×250 mm;
Waters Corporation, Milford, MA, USA) and a RI detector (RI-2031; Jasco). Statistical analysis Student's t test or Welch's test was used to determine whether body weight gain, food intake, pH, SCFA pools in the cecal contents and bile acids in the feces were significantly different between the two dietary groups (P < 0.05).
Analyses of pH and short-chain fatty acids (SCFAs) in cecal contents

RESULTS
Changes in rat cecal conditions by DFA III ingestion
There were no significant differences in body weight gain (7.69 ± 0.13 vs. 7.10 ± 0.26 g) or food intake (18.74 ± 0.36 vs. 17.52 ± 0.50 g) over the experimental period between the groups fed the control and DFA III diets. The pH of the cecal contents in the DFAIII-fed rats (5.82 ± 0.05) was lower than that in the control-fed rats (7.82 ± 0.14, P < 0.01). The pools of total SCFAs (sum of acetic, propionic and butyric acids) in the cecal contents were higher in the DFAIII group (169.3 ± 16.6 µmol/cecal content) than in the control group (135.8 ± 11.0 µmol/cecal content), and, in particular, the acetic acid pool was higher in the DFAIII group (118.5 ± 12.0 µmol/cecal content) than in the control group (88.7 ± 6.9 µmol/cecal content). However, the difference between the two groups did not reach a significant level (P = 0.057). These results suggest that the increase in the acetic acid pool mainly contributes to the lowered cecal pH as a result of DFAIII ingestion.
Identification of DFA III-assimilating bacteria DFA III-assimilating bacteria in rat cecal contents in this study were isolated, and the 16S rDNA sequences of the isolates were the same as that of Ruminococcus sp. M-1 (AB125231, similarity, 100%) isolated in a previous study (9). The isolates were also strictly anaerobic gram-positive elliptical cocci, and occurred in pairs or in short chains. They showed 98% similarity of their 16S rDNA sequences with that of R. productus ATCC 27340 T (L76595). On GAM medium after 48 h, the isolates formed smooth, opaque in the center, cream-colored colonies of approximately 2 mm in diameter. The isolates assimilated DFA III and produced mainly acetic acid. Comparing with the API 50CH and APIZYM data for the isolates and R. productus JCM 1471 T , they were similar but some exhibited varying intensities in sugar assimilation and enzyme activities. At different points, the isolates assimilated inulin weakly, and did not exhibit esterlipase C8 activity. On the basis of these results, the isolates were identified as R. productus and were named R. productus M-2 (AB196512). culture broth as determined by microscopy and the concentration of DNA extracted from this broth was 20 ng/µl. Five-fold serially diluted DNA solution was used for real-time PCR as a template, and then the standard curve was constructed (Fig. 1) . The DNA concentration was linear from 2.56 pg to 40 ng (R 2 = 0.994). When the number of R. productus M-2 cells in the culture broth was 1.3 x 10 9 cells/ml as determined by microscopy, it was 1.38 x 10 9 cells/ml as determined using this standard curve (data not shown). When 1, 10 and 100 µl of the culture broth were added to the fecal samples, the number of bacterial cells were linear (R 2 = 0.999) (data not shown). The PCR products of the fecal samples were of the target length of 70 bp and these sequences were identical to those of the target bacteria (data not shown).
The quantification of R. productus in the fecal samples is shown in Fig. 2 . R. productus cells in control-fed rats varied in individuals from 10 5 -10 7 cells/g dry feces. R. productus cells on day 1 in the DFA III-fed rats also varied in individuals from 10 5 -10 7 cells/g dry feces. In the DFA III-fed rats (D-3 and D-7), R. productus cells were present at 10 7 cells/g dry feces on day 1 and the cells were in the stationary state of 10 8 cells/g dry feces on day 4. In the DFA III-fed rats (D-2 and D-4), R. productus was present at 10 5 cells/g dry feces on day 1 and was in the stationary state of 10 9 cells/g dry feces on days 5-7. These results showed that R. productus cells in all of the DFA III-fed rats were in the stationary state of 10 8 -10 9 cells/g dry feces following a week of DFA III ingestion.
The relationship between the growth of R. productus in the DFA III-fed rats and the ratio of DFA III excreted in the fecal samples is shown in Fig. 2 . The amount of DFA III excreted in the feces was the highest (36%) on day 3 and then decreased gradually. Finally, DFA III in the feces of three rats was not detected on days 11-14 (data not shown). These results showed that 64% of the DFA III intake had already been assimilated on day 3, and almost all of the DFA III ingested was assimilated by days 11-14. After three days of feeding, the number of R. productus cells correlated with the amount of DFA III excreted in feces (correlation coefficient R = -0.58, P<0.01) (Fig. 3) .
When the number of R. productus cells increased, the amount of DFA III excreted in feces decreased.
DGGE analysis
Representative DGGE profiles of the DFA III-fed rats are shown in Fig. 4 . The arrowed bands indicate bacteria related to R. productus M-2 (AB196512, 100%). The band representing R. productus in the D-3 and D-7 profiles appeared on day 1 and increased in intensity thereafter. The detection and intensity of DGGE bands of R. productus corresponded to the results of real-time PCR (Fig. 2) . R.
productus was detected at above 10 6 cells/g dry feces. The growth of R. productus affected changes in the other bands, and, in particular, the bands in the lower part of the DGGE profiles disappeared. These bands were not identified.
Bile acids in fecal samples
The composition of bile acids in the fecal samples on days 11-14 is shown in Table 2 . The concentration of HDCA (1.73 ± 0.44 µmol/g dry feces) was the highest among the components of total bile acids in the control-fed rats and that of β-MCA (1.34 ± 0.22 µmol/g dry feces) was highest in the DFA III-fed rats.
In the control-fed rats, secondary bile acids (2.61 ± 0.55 µmol/g dry feces) accounted for 94% of the total bile acids (2.77 ± 0.56 µmol/g dry feces), while primary bile acids (1.54 ± 0.26 µmol/g dry feces) accounted for 94% of the total (1.66 ± 0.30 µmol/g dry feces) in the DFA III-fed rats. DFA III ingestion changed the composition of fecal bile acids and increased the ratio of primary bile acids. The concentration of total bile acids in the DFA III-fed rats was lower than that of the control-fed rats using the enzymatic and GC-MS methods (no significant differences).
DISCUSSION
When the rats were fed 3% DFA III for 2 weeks, 64% of the DFA III intake had already been assimilated on day 3 of DFA III ingestion and almost all of the remaining DFA III had been assimilated by the end of the experiment. The DFA III-assimilating bacterium, R. productus, in the DFA III-fed rats was in the stationary state of 10 8 -10 9 cells/g dry feces from 10 6 cells/g dry feces on day 1 within a week of DFA III ingestion. The number of R. productus cells correlated with the amount of DFA III excreted in the feces. The acetic acid produced from DFA III by R. productus lowered the pH of cecal contents to 5.8. In the control-fed rats, the secondary bile acids accounted for 94% of the total bile acids, while it was the primary bile acids in the DFA III-fed rats that accounted for 94% of the total. The concentration of total bile acids in the DFA III-fed rats was lower than that in the control-fed rats. DFA III ingestion increased the ratio of primary bile acids and changed the composition of fecal bile acids.
In this study, the cecal contents of the control-fed rats were at pH 7.8 and those of the 3% DFA III-fed rats were at pH 5.8. In previous studies, that of the cecal contents of the control-fed rats was pH 7.1-7.4 and that of the cecal contents of the 3% DFA III-fed rats was pH 5.9-6.2 (3-5). The lowering of the pH of cecal contents was attributed to DFA III ingestion. The acidification of the intestine changes the composition of intestinal microbiota and affects the activity of microbial enzymes. According to DGGE analysis, the fecal microbiota of rat was changed by DFA III ingestion, but the bacterial species whose number of cells decreased following DFA III ingestion were not identified. The optimum pH for 7α-dehydroxylase activity is 7-8, and it has been shown to be already inhibited at pH < 6.5 in vitro (21, 22) . In this study, the cecal pH in the DFA III fed rats was 5.8. Thus, acidification of the cecum also seemed to inhibit bacterial 7α-dehydroxylase activity in addition to the decrease in the ratio of secondary bile acids and the change in the composition of fecal bile acids.
DFA III ingestion significantly decreased the concentration of secondary bile acids (P < 0.01), and slightly decreased total bile acids in rat feces (no significant difference). In previous reports of human trials, the fecal concentration of total and secondary bile acids was significantly decreased by lactulose (0.3 g kg -1 twice daily for 12 weeks) (29) , highly resistant amylomaize starch (30) , inulin (15 g/d for 3 weeks) (31) and fructo-oligosaccharides (FOS) (15 g/d for 3 weeks) (31) . On the other hand, FOS (12.5 g/d for 12 days) (32) and transgalacto-oligosaccharides (TOS) (7.5 and 15 g/d for 3 weeks) (33) slightly decreased the concentration of total bile acids or secondary bile acids, but the difference between the two groups was not significant.
Patients with adenomatous polyps had higher concentrations of fecal bile acids compared with control subjects. Patients with colorectal cancer had an increased proportion of secondary fecal bile acids compared with controls. The bile acids may play a role in the development of polyps and colorectal cancer (17) . Therefore, it is better to have lower concentrations of secondary and total bile acids. In a preliminary 20 human trial (administration of 3 g/d DFA III for 11 d to a 40-year-old woman), the pH of the feces and the concentration of total bile acids and secondary bile acids was decreased. A human trial of DFA III administration should be performed and the concentration of bile acids investigated.
In conclusion, when the rats were fed 3% DFA III for 2 weeks, R. productus assimilated DFA III, produced SCFAs, and lowered the cecal pH. The acidification of rat intestine may have inhibited secondary bile acid formation, eventually decreasing the ratio of secondary bile acids in the feces, and slightly decreasing the concentration of bile acids in rat feces. Therefore, it is expected that DFA III may prevent the occurrence of colorectal cancer and be a new prebiotic candidate. 
